×

CASMED to Announce Fourth Quarter and Full-Year 2012 Financial Results and Hold Conference Call on March 7, 2013

BRANFORD, Conn., Feb. 28, 2013 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announced today that it will report its financial results for the fourth quarter and full-year 2012 on Thursday, March 7th, prior to the market's opening. Management will host a conference call to discuss these results and answer questions at 10:00 A.M. (ET) that day.

Conference call dial-in information is as follows:

  • U.S. callers: (866) 239-5859
  • International callers: (702) 495-1913

Individuals interested in listening to the live conference call via the Internet may do so by logging on to the Company's website: www.casmed.com.

A telephone replay will be available from 1:00 P.M. (ET) on March 7, 2013, through 11:59 P.M. (ET) on March 13, 2013. Replay dial-in information is as follows:

  • U.S. callers: (855) 859-2056
  • International callers: (404) 537-3406
  • Conference ID number (U.S. and international): 16912969
  • The replay will also be available at www.casmed.com.

About CASMED® – Monitoring What's Vital

CASMED is a leading developer and manufacturer of medical devices for non-invasive patient monitoring. The Company's FORE-SIGHT® Absolute Cerebral Oximeter provides a highly accurate, non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation. Direct monitoring of tissue oxygenation provides a superior and powerful tool to alert clinicians to otherwise unrecognized and dangerously low levels of oxygenation of the brain and other tissues, thereby allowing them to intervene appropriately in the care of their patients. In addition to FORE-SIGHT® Oximeters and accessories, the Company provides a line of bedside patient vital signs monitoring products, proprietary non-invasive blood pressure monitoring solutions for OEM use, neonatal intensive care supplies, and service. CASMED products are designed to provide unique monitoring solutions that are vital to patient care.

For further information regarding CASMED, visit the Company's website at www.casmed.com.

CONTACT: CAS Medical Systems, Inc. Jeffery A. Baird Chief Financial Officer 203-315-6303 ir@casmed.com Investors LHA Kim Sutton Golodetz (kgolodetz@lhai.com) (212) 838-3777 or Bruce Voss (bvoss@lhai.com) (310) 691-7100 @LHA_IR_PRSource:CAS Medical Systems, Inc.